Retatrutide: phase 2 study index
This entry points to the 2023 phase 2 publication and its matching ClinicalTrials.gov registration record for retatrutide (LY3437943). [1] [2]
North Peptides / Research Library
Source-linked study notes
Research, indexed.
A focused library of external study records for researchers who want to begin with the original source material.
Current entry